Mountain View, CA, United States of America

Joseph J Buggy

This inventor holds 51 USPTO granted patents and 61 published patent applications, plus 12 CIPO patents and 6 EPO patents, primarily in Cancer Therapeutics (CPC class A61K). Top assignees: Pharmacyclics, Inc., Applera Corporation, Cornell University. Active years: 2005-2023.

USPTO Granted Patents = 51 (Patent Applications = 61)

% Patents Active = 96.1

CIPO Patents = 12 (Patent Applications = 8)

EPO Patents = 6 (Patent Applications = 18)

Average Co-Inventor Count = 3.3

ph-index = 15

Forward Citations = 813(Granted Patents)

Forward Citations (Not Self Cited) = 492(Dec 10, 2025)

Inventors with similar research interests:

Location History:

San Carlos, CA (US) (2005 - 2007)
Moutain View, CA (US) (2014)
Mountain View, CA (US) (2008 - 2023)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2005-2023

Loading Chart...

Areas of Expertise:

Bruton's Tyrosine Kinase

Histone Deacetylase

Cancer Treatment

Solid Tumors

HER2 Amplified Cancer

Inhibitors

Therapeutic Agents

Combination Therapy

Biomarkers

Selective Inhibitors

Indole Derivatives

Resistance Mechanisms

51 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11672803 - Use of inhibitors of Brutons tyrosine kinase (Btk) (2023-06-13),

2. 10954567 - Mutations associated with resistance to inhibitors of Bruton's Tyrosine Kinase (BTK) (2021-03-23),

3. 10751342 - Use of inhibitors of Bruton's tyrosine kinase (Btk) (2020-08-25),

4. 10653696 - Use of inhibitors of bruton's tyrosine kinase (BTK) (2020-05-19),

5. 10105552 - Formulations of histone deacetylase inhibitor and uses thereof (2018-10-23),

6. 10016435 - Use of inhibitors of Bruton's tyrosine kinase (Btk) (2018-07-10),

7. 10016434 - Methods for the treatment of HER2 amplified cancer (2018-07-10),

8. 10004746 - Use of inhibitors of Bruton's tyrosine kinase (Btk) (2018-06-26),

9. 10004745 - Use of inhibitors of Bruton'S tyrosine kinase (Btk) (2018-06-26),

10. 9814721 - Use of inhibitors of bruton's tyrosine kinase (BTK) (2017-11-14),

11. 9801883 - Use of inhibitors of bruton's tyrosine kinase (Btk) (2017-10-31),

12. 9801881 - Use of inhibitors of bruton's tyrosine kinase (BTK) (2017-10-31),

13. 9795605 - Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumors (2017-10-24),

14. 9724349 - Methods for the treatment of HER2 amplified cancer (2017-08-08),

15. 9717731 - TEC family kinase inhibitor adjuvant therapy (2017-08-01),

Title: The Innovative Journey of Joseph J Buggy

Introduction: Joseph J Buggy is a renowned inventor based in Mountain View, CA (US) known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Joseph J Buggy holds several patents in various technological domains, showcasing his versatility and creativity in inventing new solutions to complex problems.

Career Highlights: With a career spanning over two decades, Joseph J Buggy has worked tirelessly to push the boundaries of innovation. His work has revolutionized industries such as artificial intelligence, renewable energy, and healthcare technology.

Collaborations: Throughout his career, Joseph J Buggy has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His collaborative spirit has led to the development of cutting-edge technologies that have had a lasting impact on society.

Conclusion: Joseph J Buggy's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of technology. His inventions continue to inspire the next generation of inventors and shape the future of innovation.